Viemed Healthcare Inc

Viemed Healthcare Inc

VMD · NASDAQ · Healthcare / Medical Devices

9.17USD+0.06 (+0.66%)

Price History

Full chart

Market Stats

Previous Close9.11
Open9.16
Day Range9.05 – 9.19
52-Week Range6.05 – 12.61
Volume160.12K
Market Cap346.98M
P/E (TTM)24.62
Forward P/E18.35
EPS0.37
Dividend Yield0.00%
Beta1.09
50-Day Avg9.65
200-Day Avg9.30

About

Viemed Healthcare, Inc., through its subsidiaries, provides home medical equipment (HME) and post-acute respiratory healthcare services in the United States. The company provides respiratory disease management solutions, including treatment of chronic obstructive pulmonary disease (COPD), which include non-invasive ventilation, percussion vests, and other therapies; and invasive and non-invasive ventilation and related equipment and supplies to patients suffering from COPD. It also sells and rents HME devices, such as non-invasive and invasive ventilators, positive airway pressure (PAP) machines, durable medical equipment, percussion vests, oxygen concentrators, and other medical equipment. In addition, the company provides neuromuscular care and oxygen therapy services; and sleep apnea management which provides sleep solutions and/or equipment, such as PAP, automatic continuous positive airway pressure, and bi-level positive airway pressure machines. Further, it offers in-home sleep apnea testing services; and breast pumps and related lactation equipment and supplies, including fulfillment and support services, as well as healthcare staffing and recruitment services. Viemed Healthcare, Inc. was founded in 2006 and is headquartered in Lafayette, Louisiana.

Company Details

  • SectorHealthcare
  • IndustryMedical Devices
  • CEOMr. Casey Hoyt
  • Employees1.44K
  • Headquarters625 East Kaliste Saloom Road, Lafayette, LA, United States, 70508, USA
  • Websitehttps://www.viemed.com

Leadership

  • Mr. Casey HoytCEO & Director · b. 1977
  • Mr. Michael B. Moore CRTPresident · b. 1977
  • Mr. Trae Paul FitzgeraldChief Financial Officer · b. 1988
  • Mr. William Todd ZehnderCOO & Director · b. 1975
  • Mr. Jeremy TrahanExecutive VP, General Counsel & Corporate Secretary · b. 1970
  • Dr. William Dana Frazier M.D.Chief Medical Officer & Director · b. 1958
  • Mr. Jerome Richard Cambre IIVice President of Sales · b. 1971
  • Mr. Michael FreemanChief Business Development Officer

Financials

Income Statement

Currency: USD2014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Revenue23.29M37.57M31.36M46.93M64.46M80.26M131.31M117.06M138.83M183.01M224.26M270.28M
Growth (%)-+61.32%-16.54%+49.66%+37.37%+24.50%+63.61%-10.85%+18.60%+31.82%+22.54%+20.52%
Cost of Revenue4.24M7.82M12.50M12.31M16.69M24.25M51.20M43.65M54.15M70.22M91.05M114.82M
Gross Profit19.05M29.08M18.86M34.62M47.77M56.01M80.11M73.41M84.68M112.78M133.20M155.46M
Gross Margin81.79%77.40%60.14%73.76%74.11%69.78%61.01%62.71%60.99%61.63%59.40%57.52%
Operating Expense9.56M18.18M18.48M25.79M37.72M47.15M53.33M61.83M76.43M98.45M115.30M134.75M
Operating Income9.49M10.90M383.00K8.82M10.06M8.86M26.78M11.58M8.25M14.33M17.90M20.71M
Operating Margin40.74%29.01%1.22%18.80%15.60%11.04%20.40%9.89%5.94%7.83%7.98%7.66%
EBITDA9.87M11.94M1.81M11.37M13.89M15.51M36.45M24.13M24.82M36.68M42.31M51.56M
EBITDA Margin42.39%31.77%5.76%24.22%21.55%19.33%27.76%20.62%17.88%20.04%18.87%19.08%
Net Income9.45M8.93M1.23M8.18M9.51M8.53M31.53M9.13M6.22M10.24M11.27M14.93M
Net Income Margin40.59%23.76%3.92%17.42%14.75%10.62%24.01%7.80%4.48%5.60%5.02%5.53%
R&D-0848.00K848.00K848.00K848.00K1.08M2.11M2.70M2.78M3.07M3.02M
R&D as % of Total Revenue-0.00%2.70%1.81%1.32%1.06%0.82%1.80%1.94%1.52%1.37%1.12%
Interest Expense48.00K87.00K323.00K272.00K181.00K314.00K509.00K318.00K197.00K424.00K776.00K1.18M
Interest Expense % of Total Revenue0.21%0.23%1.03%0.58%0.28%0.39%0.39%0.27%0.14%0.23%0.35%0.44%

Balance Sheet

Currency: USD2014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Assets10.15M22.41M24.68M37.69M53.52M82.60M112.56M117.96M117.04M154.90M177.07M214.94M
Total Liabilities1.72M10.76M11.80M13.95M21.08M38.90M30.87M23.14M19.95M41.00M43.77M71.42M
Total Equity8.43M11.65M12.88M23.74M35.03M43.70M81.69M94.82M97.09M113.89M131.39M141.54M
Cash1.64M3.15M4.34M5.10M10.41M13.36M30.98M28.41M16.91M12.84M17.54M13.50M
Total Debt713.00K6.12M6.49M5.18M3.42M19.51M11.13M6.52M694.00K10.32M6.87M15.95M
Net Debt-924.00K2.97M2.15M81.00K-6.99M6.16M-19.85M-21.89M-16.22M-2.52M-10.67M2.45M

Cash Flow

Currency: USD2014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Operating Cash Flow7.59M10.19M6.41M12.02M22.37M19.09M35.11M22.49M27.75M45.21M39.09M51.92M
Investing Cash Flow-849.00K-132.63K-936.00K-3.57M-5.30M-12.81M-8.41M-19.75M-23.98M-52.11M-30.70M-50.17M
Financing Cash Flow-5.11M-8.53M-4.29M-7.69M-11.75M-3.33M-9.07M-5.32M-15.27M2.83M-3.69M-5.79M
Capital Expenditure849.00K132.63K1.67M4.00M6.11M13.38M13.04M19.74M22.90M26.09M37.77M39.98M
Free Cash Flow6.74M9.25M4.74M8.02M16.25M5.70M22.07M2.75M4.85M19.12M1.32M11.93M
Dividends Paid3.75M6.47M000405.21K-111.01K271.79K434.12K--
FCF to OCF88.82%90.80%73.90%66.71%72.67%29.87%62.85%12.23%17.48%42.29%3.37%22.98%
Dividend Paid to FCF55.68%69.99%0.00%0.00%0.00%7.11%-4.04%5.60%2.27%--

Earnings

Report DateMay 7, 2018Aug 13, 2018Nov 5, 2018Feb 27, 2019May 6, 2019Aug 9, 2019Nov 4, 2019Mar 3, 2020May 4, 2020Aug 4, 2020Nov 4, 2020Mar 3, 2021May 3, 2021Aug 2, 2021Nov 1, 2021Mar 7, 2022May 3, 2022Aug 2, 2022Nov 1, 2022Mar 2, 2023May 8, 2023Aug 9, 2023Nov 1, 2023Mar 6, 2024May 6, 2024Aug 7, 2024Nov 6, 2024Mar 4, 2025May 7, 2025Aug 6, 2025Nov 5, 2025Mar 4, 2026May 11, 2026Aug 3, 2026Nov 4, 2026
EPS Estimate--0.060.080.080.060.070.070.080.260.090.030.050.030.040.060.060.050.040.040.040.040.090.100.070.070.060.100.060.090.090.130.090.100.12
EPS Actual0.060.060.060.050.050.050.070.060.110.480.070.120.040.040.040.100.040.020.030.060.040.060.080.090.040.080.100.100.060.080.090.140.060.07-
Surprise--0.00%-37.50%-37.50%-16.67%0.00%-14.29%37.50%84.62%-22.22%300.00%-20.00%33.33%0.00%66.67%-33.33%-60.00%-25.00%50.00%0.00%50.00%-11.11%-10.00%-42.86%14.29%66.67%4.10%0.00%-11.11%0.00%7.69%-33.33%-30.00%-
TimingAfter-hoursAfter-hoursPre-marketAfter-hoursAfter-hoursPre-marketAfter-hoursPre-marketAfter-hoursAfter-hoursAfter-hoursPre-marketAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hours-After-hoursAfter-hours

Key Statistics & Ratios

Market Cap346.98M
Enterprise Value336.48M
Trailing P/E24.62
Forward P/E18.35
PEG Ratio1.84
Price / Sales1.15
Price / Book2.33
EPS0.37
Book Value3.78
Revenue (TTM)301.61M
Gross Profit (TTM)173.32M
EBITDA55.80M
Profit Margin4.81%
Operating Margin6.48%
Return on Equity10.45%
Return on Assets8.21%
Shares Outstanding38.09M
Shares Float30.64M
Beta1.09
Dividend Yield0.00%
Dividend Rate0.00
Payout Ratio0.00%

Analyst Ratings

Strong Buy
Based on 3 analystsTarget 12.50
  • Strong Buy
    3

Ownership Breakdown

Institutions
71.19%
Insiders
13.93%
Retail / Other
14.88%

Top Institutional Holders

  • BlackRock Inc
    4.62M12.14%
  • Forager Capital Management, LLC
    2.14M5.62%
  • The Goldman Sachs Group Inc
    1.42M3.73%
  • Vanguard Capital Management, LLC
    1.30M3.42%
  • Arnhold & S. Bleichroeder Advisers, LLC
    1.07M2.81%
  • Ameriprise Financial Inc
    898.32K2.36%
  • Nantahala Capital Management, LLC
    883.78K2.32%
  • Geode Capital Management, LLC
    779.52K2.05%
  • State Street Corp
    742.96K1.95%
  • Arrowstreet Capital Limited Partnership
    711.19K1.87%
  • Panagora Asset Management Inc
    538.63K1.41%
  • Punch & Associates Inv Mgmt Inc
    533.47K1.40%
  • Tocqueville Asset Management L.P.
    472.10K1.24%
  • Renaissance Technologies Corp
    442.20K1.16%
  • Two Sigma Investments LLC
    438.85K1.15%

Top Fund Holders

  • Vanguard MStar Total Stk Mkt Idx Invest
    912.71K2.40%
  • iShares Russell 2000 ETF
    857.01K2.25%
  • Columbia Small Cap Value Discv A
    566.63K1.49%
  • BlackRock Advantage Small Cap Core Instl
    478.28K1.26%
  • First Eagle Small Cap Opportunity I
    467.35K1.23%